Abstract:Naïve CD4+ Th (T helper cells) can differentiate/be polarized in to 9 terminally differentiated Th cell subsets depending on the cytokine repertoire and anatomical location. CD4+ FOXP3+ (forkhead box P3) regulatory T cells (Treg) are one of the Th subsets. Treg are well known to suppress immuno‐pathological reactions in host immune system against antigens and dangers. Recently we proposed a novel concept, which suggested that pathological conditions re‐shape physiological Treg into pathological Treg that have weakened immuno‐suppressive functions and show increased plasticity. This was substantiated by several reports by demonstrating that there are endogenous mechanisms available to suppress Treg under various pathologies. Furthermore, Th1 like–Treg and Th17 like–Treg have also been reported. However, a comprehensive analysis was not conducted to identify whether Treg can convert into other immune cell types such as APCs (antigen presenting cells) when given the right condition. To test this hypothesis, we conducted an extensive experimental datamining approach. In our study, we analyzed the tissue expression patterns of as many as 61 Th subset regulators in physiological and pathological conditions. Our analysis revealed the following findings. 1) All the Th subset regulators are differentially expressed in various human tissues including heart and vascular tissues at physiological conditions. 2) Chronic metabolic diseases and autoimmune diseases increase multiple Th subset regulators but decrease Treg regulators. Familial hypercholesterolemia and lupus do not increase Th1 regulators. 3) Severe trauma increases Th2, Th9, Tfh, and Th17 subset regulators but decreases Th1 and Treg regulators in blood. In contrast, burn injury decreases all Th subset regulators except Th22 regulators. 4) Vascular cells are functional as innate immune cells, express numerous Th subsets‐promoting cytokines and induce Th regulator expression except the regulators for Treg. 5) Gata3 and Hdac6 promote, but Bcl6 inhibits, Th subset regulator expression in Treg, and regulate Treg plasticity and heterogeneity. 6) Gata3 and Bcl6 inhibit the expression of MHC class II, and T cell co‐signaling receptors in Treg; and consequently mutations of Gata3 and Bcl6 “trans‐differentiate” Treg into APC‐like Treg. Based on our findings, we conclude that increased plasticity of naïve T‐reg under pathological conditions with decreased expression of Gata3 and Bcl6 can upregulate MHC class II molecules and T cell co‐stimulation receptors expression that subsequently convert them to APC like‐Treg. Furthermore, our data suggested that Th subset may have various non‐immune activities as well. Our findings provide novel insights into Th subsets and Treg, which may lead to future development of novel therapeutics for the treatment of inflammation, cancers, transplantation, autoimmune diseases and tissue regeneration.Support or Funding InformationRO1‐HL132399‐01A1This abstract is from the Experimental Biology 2018 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.

Increased Plasticity of FOXP3+ Treg under Pathological Conditions Convert Treg into Either Novel Treg or Th1‐Treg

Tgf-Beta-Induced Regulatory T Cells Directly Suppress B Cell Responses Through A Noncytotoxic Mechanism

GATA3, HDAC6, and BCL6 Regulate FOXP3+ Treg Plasticity and Determine Treg Conversion into Either Novel Antigen-Presenting Cell-Like Treg or Th1-Treg.

Pathological Conditions Re-Shape Physiological Tregs into Pathological Tregs

Regulatory dendritic cells program generation of interleukin-4–producing alternative memory CD4 T cells with suppressive activity

Treg plasticity and human diseases

Molecular Insights Into Regulatory T-Cell Adaptation to Self, Environment, and Host Tissues: Plasticity or Loss of Function in Autoimmune Disease

Molecular Antagonism and Plasticity of Regulatory and Inflammatory T Cell Programs

Tissue Treg Secretomes and Transcription Factors Shared With Stem Cells Contribute to a Treg Niche to Maintain Treg-Ness With 80% Innate Immune Pathways, and Functions of Immunosuppression and Tissue Repair

BCL6 Inhibits CD4+Foxp3+ Regulatory T Cell Trans‐differentiation into Macrophage‐like Cells Via Modulation of Chromatin Long‐range Interactions

A Minimal Regulatory Network of Extrinsic and Intrinsic Factors Recovers Observed Patterns of CD4+ T Cell Differentiation and Plasticity

Many Faces of Regulatory T Cells: Heterogeneity or Plasticity?

Translational mini-review series on Th17 cells: induction of interleukin-17 production by regulatory T cells

Conversion of Peripheral CD4+CD25− Naive T Cells to CD4+CD25+ Regulatory T Cells by TGF-β Induction of Transcription Factor Foxp3

Regulatory T Cells: the Many Faces of Foxp3

Excess generation and activation of naturally arising memory-phenotype CD4+ T lymphocytes are inhibited by regulatory T cells in steady state

Generation of human Th1-like regulatory CD4+ T cells by an intrinsic IFN-γ- and T-bet-dependent pathway.

A Novel Subset of Regulatory T Cells Induced by B Cells Alleviate the Severity of Immunological Diseases

Improving regulatory T cell-based therapy: insights into post-translational modification regulation

The canonical Hippo pathway components modulate the differentiation of lamina propria regulatory T cells and T helper 17-like regulatory T cells in mouse colitis

Regulatory T Cells: Regulation of Identity and Function